Literature DB >> 5015332

Treatment for Parkinsonism, other than levodopa.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5015332      PMCID: PMC1787626          DOI: 10.1136/bmj.1.5802.741

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  15 in total

1.  Parkinson's syndrome.

Authors:  A C ENGLAND; R S SCHWAB
Journal:  N Engl J Med       Date:  1961-10-26       Impact factor: 91.245

2.  Mental symptoms in parkinsonism following benzhexol hydrochloride therapy.

Authors:  H B PORTEOUS; D N ROSS
Journal:  Br Med J       Date:  1956-07-21

3.  On the mode of action of amantadine.

Authors:  U Stromberg; T H Svensson; B Waldeck
Journal:  J Pharm Pharmacol       Date:  1970-12       Impact factor: 3.765

4.  Amantadine for Parkinson's disease.

Authors:  C Fieschi; M Nardini; M Casacchia; M E Tedone
Journal:  Lancet       Date:  1970-05-02       Impact factor: 79.321

5.  Combined treatment of parkinsonism with L-dopa and amantadine.

Authors:  K R Hunter; G M Stern; D R Laurence; P Armitage
Journal:  Lancet       Date:  1970-09-12       Impact factor: 79.321

6.  Amantadine in parkinsonism.

Authors:  K R Hunter; G M Stern; D R Laurence; P Armitage
Journal:  Lancet       Date:  1970-05-30       Impact factor: 79.321

7.  Controlled trial of amantadine hydrochloride in Parkinson's disease.

Authors:  J D Parkes; D M Calver; K J Zilkha; R P Knill-Jones
Journal:  Lancet       Date:  1970-02-07       Impact factor: 79.321

8.  Amantadine for Parkinson's disease.

Authors:  D C Mann; L A Pearce; L D Waterbury
Journal:  Neurology       Date:  1971-09       Impact factor: 9.910

9.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

10.  Amantadine versus L-2 dopa and amatadine plus L-dopa.

Authors:  C Fieschi; M Nardini; M Casacchia; M E Tedone; M Reitano; E Robotti
Journal:  Lancet       Date:  1970-07-18       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.